Digital Mammography Best for Young Women With Dense Breasts

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 16 No 1
Volume 16
Issue 1

New subgroup analyses from the Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group confirm previous results that digital screening mammography is significantly more accurate than film screening mammography in young women with dense breasts but not in women overall.

CHICAGO—New subgroup analyses from the Digital Mammographic Imaging Screening Trial (DMIST) Investigators Group confirm previous results that digital screening mammography is significantly more accurate than film screening mammography in young women with dense breasts but not in women overall. Etta Pisano, MD, of the University of North Carolina School of Medicine, Chapel Hill, reported the data at the 2006 Radiological Society of North America meeting (abstract SSA15-02).

DMIST enrolled 49,528 women from 33 imaging centers in the US and Canada. All of the women had both digital and film mammography, interpreted by two readers. Findings were available for 42,760 women who underwent biopsy for a suspicious lesion or who had 1-year follow-up examination. Primary results from the study published in 2005 included 15 data analyses. The results presented at RSNA included 10 additional analyses.

The new analyses of DMIST data indicated that digital mammography was significantly better than film mammography for detecting breast cancer in one group of women—pre- or perimenopausal women with dense breast tissue (P = .0015). However, as in the original analyses, digital technology did not confer a diagnostic advantage in detecting breast cancer across-the-board. According to Dr. Pisano, subgroup analyses showed no significant difference between digital and analog mammography in breast cancer screening for any other segment of women classified by age, menopausal status, and breast density. The subgroup analyses also showed that analog mammography was slightly superior to digital technology for screening women over age 65 with fatty breasts, although the difference was not significant, she said.

Dr. Pisano believes the results favoring digital mammography in younger women with dense breasts may be due to differences in contrast. "My hypothesis is that contrast for digital mammography has been optimized for dense breasts, but not for fatty breasts," she said.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.
Related Content